Global /South Korea /Healthcare /Drug Manufacturers - General /041910

Polaris AI Pharma Corp.

041910

• KRX: 041910 • Delayed

7,130KRW 2.7%

4.72 USD

As of 20 June 2026, Polaris AI Pharma Corp. has a market cap of $64.45M USD, ranking #28711 globally and #1542 in South Korea. It ranks #2606 in the Healthcare sector, and #925 in the Drug Manufacturers - General industry.

Global Rank

28711

Country Rank

1542

Sector Rank

2606

Industry Rank

925

Key Stats

Market Cap

$64.45MUSD

99.36B KRW

Revenue (TTM)

$41.47MUSD

63.94B KRW

EBITDA (TTM)

$3.83MUSD

5.78B KRW

Net Income (TTM)

$641.86KUSD

989.48M KRW

EBITDA Margin

Profit Margin

1.5%

PE Ratio

88.3

PS Ratio

1.6

PB Ratio

0.8

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jae-Chul Kim open_in_new

Employees

160

Founded

1996

Website

polarisaipharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.7%	3.5%	-4.3%	2.3%	9%	14%	22%	-5.3%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	041910 폴라리스AI파마 ISIN: KR7041910001 Shares Out.: Shares Outstanding: 13.065M¹ Shares Float: 8.929M² TV: TradingView: KRX: 041910 SA: Stock Analysis: KRX: 041910 YF: Yahoo Finance: 041910.KS GF: Google Finance: KRX: 041910 BA: Barron's: 041910 MS: Morningstar: XKRX: 041910	7,130 KRW	TV: TradingView: KRX: 041910 SA: Stock Analysis: KRX: 041910 YF: Yahoo Finance: 041910.KS GF: Google Finance: KRX: 041910 BA: Barron's: 041910 MS: Morningstar: XKRX: 041910

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Polaris AI Pharma Corp.

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.02B 13.91T KRW 14K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.68B 10.3T KRW 10K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.17B 7.97T KRW 8K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.9B 7.55T KRW 7K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.49B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.38B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 849K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 559K%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 494K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 442K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 425K%	15.1	United States

chevron_leftBack